ImmunityBio, Inc. Share Price
NASDAQ: IBRX | Mid CapImmunityBio, Inc. Stock Performance
Open $7.50 | Prev. Close $7.63 | Circuit Range N/A |
Day Range $7.42 - $7.69 | Year Range $1.95 - $12.38 | Volume 3,16,623 |
Average Traded $7.52 |
ImmunityBio, Inc. Share Price Today
As of 11 August 2026, ImmunityBio, Inc.'s share price is $7.50. The stock opened at $7.50, compared to its previous close of $7.63. During today's trading session, ImmunityBio, Inc.'s share price traded between $7.42 and $7.69, with an average price of $7.55. Over the past 52 weeks, the stock has recorded a high of $12.38 and a low of $1.95. In terms of performance, ImmunityBio, Inc.'s share price has declined by 23.39% over the last six months and is up 220.51% on a year-on-year basis.
ImmunityBio, Inc. Share Price Chart
ImmunityBio, Inc. Stock Fundamentals & Key Indicators
Market Cap $6.90B | PE Ratio (TTM) -19.74 | Dividend Yield N/A |
EPS (TTM) $-0.38 | Revenue (TTM) $113.29M | Return On Equity (TTM) 70.23% |
Profit Margin -310.25% | Debt to Equity -0.12 | Quarterly Earnings Growth YoY 21.55% |
ImmunityBio, Inc. Quarterly Profit & Loss
All figures in USD
ImmunityBio, Inc. Annual Profit & Loss
All figures in USD
About ImmunityBio, Inc.
ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.
ImmunityBio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $7.17 | $7.63 | +6.49% |
Jul 2026 | $8.68 | $7.17 | -17.96% |
Jun 2026 | $7.38 | $8.74 | +16.30% |
May 2026 | $6.97 | $7.51 | +5.85% |
Apr 2026 | $7.53 | $7.10 | -7.13% |
Mar 2026 | $9.66 | $7.64 | -21.91% |
Feb 2026 | $6.29 | $9.79 | +56.14% |
Jan 2026 | $2.02 | $6.27 | +217.47% |
Dec 2025 | $2.38 | $1.98 | -16.14% |
Nov 2025 | $2.38 | $2.35 | -1.46% |
Oct 2025 | $2.45 | $2.39 | -2.45% |
Sep 2025 | $2.34 | $2.45 | +4.70% |
IBRX Share Price FAQs
What is ImmunityBio, Inc. share price today?
What is the 52 week high and 52 week low of ImmunityBio, Inc. stock?
What is IBRX's market capitalisation today?
What is IBRX's net income for the last quarter?
What is the 5 year returns of IBRX?
What is the high & low stock price of IBRX today?
Can I buy IBRX shares in India?